Logo image of BBH

VANECK BIOTECH ETF (BBH) Stock Overview

USA - NASDAQ:BBH - US92189F7261 - ETF

179.176 USD
+2.53 (+1.43%)
Last: 10/20/2025, 8:00:01 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BBH. BBH was compared to 83 industry peers in the Automobile Components industry. Both the profitability and the financial health of BBH get a neutral evaluation. Nothing too spectacular is happening here. BBH is valied quite expensively at the moment, while it does show a decent growth rate. Finally BBH also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BBH had positive earnings in the past year.
BBH had a positive operating cash flow in the past year.
In the past 5 years BBH has always been profitable.
In the past 5 years BBH always reported a positive cash flow from operatings.
BBH Yearly Net Income VS EBIT VS OCF VS FCFBBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.39%, BBH is in line with its industry, outperforming 45.78% of the companies in the same industry.
BBH has a Return On Equity (8.81%) which is in line with its industry peers.
BBH has a Return On Invested Capital (8.17%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for BBH is in line with the industry average of 8.51%.
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROIC 8.17%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
BBH Yearly ROA, ROE, ROICBBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 5.84%, BBH perfoms like the industry average, outperforming 49.40% of the companies in the same industry.
In the last couple of years the Profit Margin of BBH has remained more or less at the same level.
BBH has a Operating Margin of 10.65%. This is comparable to the rest of the industry: BBH outperforms 50.60% of its industry peers.
BBH's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 27.60%, BBH perfoms like the industry average, outperforming 42.17% of the companies in the same industry.
In the last couple of years the Gross Margin of BBH has remained more or less at the same level.
Industry RankSector Rank
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
BBH Yearly Profit, Operating, Gross MarginsBBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BBH is creating some value.
The number of shares outstanding for BBH has been reduced compared to 1 year ago.
BBH has less shares outstanding than it did 5 years ago.
BBH has a worse debt/assets ratio than last year.
BBH Yearly Shares OutstandingBBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BBH Yearly Total Debt VS Total AssetsBBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

BBH has an Altman-Z score of 5.53. This indicates that BBH is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BBH (5.53) is better than 87.95% of its industry peers.
The Debt to FCF ratio of BBH is 6.05, which is on the high side as it means it would take BBH, 6.05 years of fcf income to pay off all of its debts.
BBH has a Debt to FCF ratio of 6.05. This is in the lower half of the industry: BBH underperforms 63.86% of its industry peers.
BBH has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
BBH has a Debt to Equity ratio of 0.32. This is in the lower half of the industry: BBH underperforms 62.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Altman-Z 5.53
ROIC/WACC1.04
WACC7.88%
BBH Yearly LT Debt VS Equity VS FCFBBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

BBH has a Current Ratio of 1.80. This is a normal value and indicates that BBH is financially healthy and should not expect problems in meeting its short term obligations.
BBH's Current ratio of 1.80 is on the low side compared to the rest of the industry. BBH is outperformed by 72.29% of its industry peers.
A Quick Ratio of 1.12 indicates that BBH should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.12, BBH is not doing good in the industry: 73.49% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.12
BBH Yearly Current Assets VS Current LiabilitesBBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

BBH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.28%.
Measured over the past 5 years, BBH shows a small growth in Earnings Per Share. The EPS has been growing by 1.64% on average per year.
The Revenue has decreased by -3.62% in the past year.
The Revenue has been growing slightly by 2.41% on average over the past years.
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%

3.2 Future

The Earnings Per Share is expected to grow by 15.63% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.47% on average over the next years.
EPS Next Y21.13%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
EPS Next 5YN/A
Revenue Next Year-2%
Revenue Next 2Y0.2%
Revenue Next 3Y1.31%
Revenue Next 5Y2.47%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BBH Yearly Revenue VS EstimatesBBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
BBH Yearly EPS VS EstimatesBBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

0

4. Valuation

4.1 Price/Earnings Ratio

BBH is valuated quite expensively with a Price/Earnings ratio of 70.27.
BBH's Price/Earnings ratio is a bit more expensive when compared to the industry. BBH is more expensive than 75.90% of the companies in the same industry.
BBH's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.69.
BBH is valuated quite expensively with a Price/Forward Earnings ratio of 41.89.
BBH's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. BBH is more expensive than 78.31% of the companies in the same industry.
BBH is valuated expensively when we compare the Price/Forward Earnings ratio to 23.18, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 70.27
Fwd PE 41.89
BBH Price Earnings VS Forward Price EarningsBBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

BBH's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BBH is more expensive than 75.90% of the companies in the same industry.
BBH's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. BBH is more expensive than 73.49% of the companies in the same industry.
Industry RankSector Rank
P/FCF 87.5
EV/EBITDA 23.19
BBH Per share dataBBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as BBH's earnings are expected to grow with 15.63% in the coming years.
PEG (NY)3.33
PEG (5Y)42.77
EPS Next 2Y18.35%
EPS Next 3Y15.63%

7

5. Dividend

5.1 Amount

BBH has a Yearly Dividend Yield of 5.09%, which is a nice return.
BBH's Dividend Yield is rather good when compared to the industry average which is at 4.48. BBH pays more dividend than 96.39% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, BBH pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.09%

5.2 History

On average, the dividend of BBH grows each year by 7.84%, which is quite nice.
BBH has been paying a dividend for at least 10 years, so it has a reliable track record.
BBH has decreased its dividend recently.
Dividend Growth(5Y)7.84%
Div Incr Years1
Div Non Decr Years1
BBH Yearly Dividends per shareBBH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

BBH pays out 62.40% of its income as dividend. This is not a sustainable payout ratio.
The dividend of BBH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.4%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
BBH Yearly Income VS Free CF VS DividendBBH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
BBH Dividend Payout.BBH Dividend Payout, showing the Payout Ratio.BBH Dividend Payout.PayoutRetained Earnings

VANECK BIOTECH ETF

NASDAQ:BBH (10/20/2025, 8:00:01 PM)

179.176

+2.53 (+1.43%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)02-22 2026-02-22/amc
Inst Owners46.28%
Inst Owner Change-0.14%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap126.45B
Analysts80
Price Target197.87 (10.43%)
Short Float %0%
Short Ratio1.02
Dividend
Industry RankSector Rank
Dividend Yield 5.09%
Yearly Dividend1.58
Dividend Growth(5Y)7.84%
DP62.4%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.9%
PT rev (3m)8.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.32%
EPS NY rev (3m)-10.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-2.81%
Valuation
Industry RankSector Rank
PE 70.27
Fwd PE 41.89
P/S 4.06
P/FCF 87.5
P/OCF 32.07
P/B 6.12
P/tB 8.32
EV/EBITDA 23.19
EPS(TTM)2.55
EY1.42%
EPS(NY)4.28
Fwd EY2.39%
FCF(TTM)2.05
FCFY1.14%
OCF(TTM)5.59
OCFY3.12%
SpS44.16
BVpS29.27
TBVpS21.54
PEG (NY)3.33
PEG (5Y)42.77
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROCE 10.41%
ROIC 8.17%
ROICexc 9.37%
ROICexgc 11.66%
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
FCFM 4.64%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.37%
ROICexc(5y)9.81%
ROICexgc(3y)12.78%
ROICexgc(5y)12.13%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-1.65%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-2.16%
ROICexc growth 5Y0.21%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Debt/EBITDA 1.17
Cap/Depr 107.96%
Cap/Sales 8.01%
Interest Coverage 9.96
Cash Conversion 70%
Profit Quality 79.44%
Current Ratio 1.8
Quick Ratio 1.12
Altman-Z 5.53
F-Score5
WACC7.88%
ROIC/WACC1.04
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
EPS Next Y21.13%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
Revenue Next Year-2%
Revenue Next 2Y0.2%
Revenue Next 3Y1.31%
Revenue Next 5Y2.47%
EBIT growth 1Y-17.5%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year59.12%
EBIT Next 3Y22.78%
EBIT Next 5Y17.41%
FCF growth 1Y-20.46%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-10.1%
OCF growth 3Y14.27%
OCF growth 5Y5.48%